G MEDICAL INNOVATION HOLDING (GMVD) Forecast, Price Target & Analyst Ratings

NASDAQ:GMVD • KYG394621414

Current stock price

0.181 USD
0 (0%)
At close:
0.154 USD
-0.03 (-14.92%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for G MEDICAL INNOVATION HOLDING (GMVD).

Forecast Snapshot

Consensus Price Target

Price Target
$4.08
+ 2,154.14% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2021
EPS Estimate
-$13.92
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.08
Upside
+ 2,154.14%
From current price of $0.18 to mean target of $4.08, Based on 7 analyst forecasts
Low
$4.04
Median
$4.08
High
$4.20

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for GMVD. The average price target is 4.08 USD. This implies a price increase of 2154.14% is expected in the next year compared to the current price of 0.181.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

GMVD Current Analyst RatingGMVD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

GMVD Historical Analyst RatingsGMVD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
GMVD was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GMVD.
In the previous month the buy percentage consensus was at a similar level.
GMVD was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-06-20ThinkEquityInitiate Buy
2022-01-18EF HuttonInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2021
EPS Estimate
-$13.92
Revenue Estimate
N/A
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2021 - 2024

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2017 2018 2019 2021 2023 2024
Revenue
YoY % growth
GMVD revenue by date.GMVD revenue by date.
109K3.062M
2,709.17%		5.526M
80.47%		N/A13.447M35.19M
161.69%
EBITDA
YoY % growth
GMVD ebitda by date.GMVD ebitda by date.
-26.299M
-894.29%		-14.086M
46.44%		-9.909M
29.65%		N/AN/AN/A
EBIT
YoY % growth
GMVD ebit by date.GMVD ebit by date.
-26.521M
-896.28%		-17.184M
35.21%		-12.779M
25.63%		N/A-7.681M255K
103.32%
Operating Margin
GMVD operating margin by date.GMVD operating margin by date.
-24,331.19%-561.20%-231.25%N/A-57.12%0.72%
EPS
YoY % growth
GMVD eps by date.GMVD eps by date.
N/AN/AN/A-46.41-0.650.06
109.38%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 21
EPS
Q2Q % growth		-13.92
Revenue
Q2Q % growth		N/A
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		N/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

GMVD Yearly Revenue VS EstimatesGMVD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2023 2024 10M 20M 30M
GMVD Yearly EPS VS EstimatesGMVD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2023 2024 0 -10 -20 -30 -40

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

G MEDICAL INNOVATION HOLDING / GMVD Forecast FAQ

What do analysts expect the price target to be for G MEDICAL INNOVATION HOLDING (GMVD)?

7 analysts have analysed GMVD and the average price target is 4.08 USD. This implies a price increase of 2154.14% is expected in the next year compared to the current price of 0.181.